Menu
GeneBe

rs397515337

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4

The NM_006642.5(SDCCAG8):c.740+356C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000828 in 217,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

SDCCAG8
NM_006642.5 intron

Scores

2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: -0.970
Variant links:
Genes affected
SDCCAG8 (HGNC:10671): (SHH signaling and ciliogenesis regulator SDCCAG8) This gene encodes a centrosome associated protein. This protein may be involved in organizing the centrosome during interphase and mitosis. Mutations in this gene are associated with retinal-renal ciliopathy. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-243305133-C-T is Pathogenic according to our data. Variant chr1-243305133-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 60.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-243305133-C-T is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).. Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SDCCAG8NM_006642.5 linkuse as main transcriptc.740+356C>T intron_variant ENST00000366541.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SDCCAG8ENST00000366541.8 linkuse as main transcriptc.740+356C>T intron_variant 1 NM_006642.5 P1Q86SQ7-1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
151982
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000124
AC:
1
AN:
8058
Hom.:
0
AF XY:
0.000217
AC XY:
1
AN XY:
4600
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000300
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000122
AC:
8
AN:
65308
Hom.:
0
Cov.:
0
AF XY:
0.000109
AC XY:
4
AN XY:
36828
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000173
Gnomad4 OTH exome
AF:
0.000320
GnomAD4 genome
AF:
0.0000658
AC:
10
AN:
151982
Hom.:
0
Cov.:
32
AF XY:
0.0000539
AC XY:
4
AN XY:
74232
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000693
Hom.:
0
Bravo
AF:
0.0000718

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bardet-Biedl syndrome 16 Pathogenic:2
Pathogenic, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and HarvardJun 26, 2017PVS1: This is an intronic variant in most transcripts but there is functional evidence in the literature that it results in altered splicing and significantly reduced protein levels (PMID: 20835237). It is annotated as a missense here but that only applies to 1 transcript. PP1 it cosegregates in 1 large Gypsy family with 5 affected individuals in 2 sibships (PMID: 22190896). PM2 rare in population databases (AC = 2 in gnomAD). -
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2011- -
SDCCAG8-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesDec 27, 2022The SDCCAG8 c.740+356C>T variant is predicted to interfere with splicing. This variant has been reported in the homozygous state in 5 affected individuals from two related Roma families with Bardet-Biedl syndrome (BBS) (Otto et al. 2010. PubMed ID: 20835237; Schaefer et al. 2011. PubMed ID: 22190896). Although this family was diagnosed with BBS, they were initially recruited due to acute manifestation of chronic renal failure coupled with respiratory defects. This deep intronic variant was predicted to disrupt an exonic splicing enhancer which was confirmed by cDNA sequencing (Otto et al. 2010. PubMed ID: 20835237). This variant was also described in the compound heterozygous state in an individual with Senior-Loken syndrome (Tay and Vincent. 2020. PubMed ID: 32432520) and in the homozygous state in an individual with suspected retinal disease (Weisschuh et al. 2020. PubMed ID: 32531858, supplementary data). Lastly, this variant was detected, along with a second causative variant, in another individual with Bardet-Biedl syndrome (Meyer et al. 2022. PubMed ID: 35112343). This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-243468435-C-T). This variant is interpreted as likely pathogenic. -
Senior-Loken syndrome 7 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingMolecular Diagnostics Laboratory, M Health Fairview: University of MinnesotaJun 01, 2018- -
Senior-Loken syndrome 7;C3889474:Bardet-Biedl syndrome 16 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 30, 2021- -
Bardet-Biedl syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 17, 2022Variant summary: SDCCAG8 c.740+356C>T is located at a position not widely known to affect splicing. 4/4 computational tools predict no significant impact on normal splicing. However, at least one publication reports experimental evidence that this variant affects mRNA splicing. The variant allele was found at a frequency of 0.00012 in 8058 control chromosomes. c.740+356C>T has been reported in the literature in multiple individuals affected with retinal-renal ciliopathy. These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
Cadd
Benign
3.7
Dann
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397515337; hg19: chr1-243468435; API